European equity research this week tilts constructive on quality single names, but cautious on the near-term tape.
One strand of published analysis argues specialist Swiss companies with steady growth have been overshadowed by AI enthusiasm, yet keep compounding shareholder value — Straumann in dental implants and Sonova in hearing care are cited as long-term examples. Lindt & Sprüngli is flagged as a margin-recovery story as pricing adjusts and cocoa hedges roll to lower levels.
A separate camp of analysts likes ASML for its scarce AI-infrastructure position and sees Amadeus as more attractive after AI-disruption fears compressed the valuation. The same thread turned negative on Diageo after the dividend cut, pointing to weaker demand and free-cash-flow pressure.
Near-term, researchers note pre-open indications had the DAX starting below 25,800 versus Friday's 25,820 close, with nerves around AI and semis and US CPI tomorrow. A contrarian political read suggests European defence and drone names could weaken if the next US Congress doesn't lift defence budgets.